SCHEMBL7716686

SCHEMBL7716686

Nc1ncc(Oc2ccc(F)cc2Cl)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
ROCK2 O75116 2/20 0.40
ROCK1 Q13464 2/20 0.40
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
MAPT P10636 1/20 0.37
SOS1 Q07889 1/20 0.36
ADORA2A P29274 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
METAP1 P53582 1/20 0.36
SCN9A Q15858 1/20 0.36
RPS6KB1 P23443 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
PDE4B Q07343 1/20 0.35
HTR2A P28223 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8133641 0.94 HTR3E (0.38) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7713453 0.90 HTR3E (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7708465 0.90 HTR7 (0.43) ROCK2ROCK1MAPTHRH4METAP1
SCHEMBL7712404 0.88 METAP1 (0.44) ROCK2ROCK1METAP1LMNATP53
SCHEMBL7708476 0.86 ROCK2 (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7714141 0.84 SCN9A (0.47) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7714357 0.83 HTR3E (0.43) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7714566 0.82 ROCK2 (0.41) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7712407 0.82 HTR1A (0.46) ROCK2ROCK1MAPTHRH4METAP1
SCHEMBL7714281 0.82 HTR3E (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed